Skip to navigation Skip to content

News

Share

Webcast: Research Advances from the World’s Largest MS Meeting

September 13, 2014

 "Research Advances from the World’s Largest MS Meeting"
Join a panel of experts in this nationwide webcast recorded Saturday September 13, 2014

Topics include:

  • Progressive MS
  • Genetics
  • Wellness and rehabilitation
  • Repair and protection

Moderator: Kate Milliken, founder, Milligrace Productions. Kate has been living with MS since 2006.

Panelists include:

Dr. Philip DeJager, Brigham and Women’s Hospital, Boston, MA

Dr. Don Mahad, University of Edinburgh, UK

Dr. Ellen Mowry, Johns Hopkins University, Baltimore, MD

Dr. Timothy Coetzee, Chief Advocacy, Services and Research Officer for the National MS Society

Watch Now

We want to thank Biogen Idec; Genzyme, a Sanofi Company; Novartis Pharmaceuticals; Questcor Pharmaceuticals; and Walgreens Specialty Pharmacy for providing generous educational grants that made this program possible.

About Multiple Sclerosis

Multiple sclerosis is an unpredictable, often disabling disease of the central nervous system. Symptoms range from numbness and tingling to blindness and paralysis, and there is currently no cure for MS. The progress, severity and specific symptoms of MS in any one person cannot yet be predicted, but advances in research and treatment are leading to better understanding and moving us closer to a world free of MS. An estimated 1 million people live with MS in the United States. Most people with MS are diagnosed between the ages of 20 and 50, and it affects women three times more than men.

Share


© 2020 The National Multiple Sclerosis Society is a tax exempt 501(c)3 nonprofit organization and our Identification Number (EIN) is 13-5661935.